MV Capital Management Inc. Sells 344 Shares of Cardinal Health, Inc. $CAH

MV Capital Management Inc. decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 54.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 288 shares of the company’s stock after selling 344 shares during the period. MV Capital Management Inc.’s holdings in Cardinal Health were worth $48,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of CAH. Atlantic Edge Private Wealth Management LLC lifted its holdings in shares of Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after purchasing an additional 75 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health during the 1st quarter worth $26,000. NewSquare Capital LLC increased its position in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after buying an additional 107 shares in the last quarter. GW&K Investment Management LLC increased its position in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after buying an additional 144 shares in the last quarter. Finally, Harbor Asset Planning Inc. purchased a new stake in Cardinal Health in the second quarter valued at about $49,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CAH shares. Leerink Partners boosted their price target on Cardinal Health from $187.00 to $211.00 in a research note on Friday, October 31st. Wells Fargo & Company upped their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Evercore ISI raised their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a report on Friday, October 31st. TD Cowen boosted their price objective on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Finally, Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $205.00.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares in the company, valued at $2,228,728.32. The trade was a 47.41% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 271,676 shares of company stock valued at $40,489,525 in the last 90 days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Price Performance

CAH stock opened at $205.94 on Friday. The company has a market capitalization of $48.93 billion, a P/E ratio of 31.93, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. Cardinal Health, Inc. has a 12 month low of $114.60 and a 12 month high of $207.47. The firm’s fifty day simple moving average is $164.46 and its 200-day simple moving average is $158.49.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the previous year, the firm posted $1.88 earnings per share. The firm’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.